🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan

RecruitingPhase 3Ages 30 Years - 60 YearsAllAbdul Bari
NCT06852079 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The herbal medicine Qurs-e-Fishar to treat mild to moderate High blood pressure or hypertension comprises of Rauwolfia serpentina. A product of Hamdard Laboratories (Waqf) Pakistan. A Phase III Safety \& Efficacy Open-label, Single-Arm, Interventional, Multicenter, Study in mild to moderate hypertensive, adults (30 to 60 years of age) prescribed with study product for 12 weeks (84 days). Primary End Points: 1. Reduction in diastolic blood pressure less than 130 / 80 mmHg at the end of the study period (accepted by WHO) or if there was a fall of 20 / 10 mmHg or more in diastolic blood pressure as compared to baseline. 2. Type, frequency and severity of ADRs during the study period. Secondary End Points: 1\. Compliance of the prescribed study medication.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Ability to sign ICD * Participant(s) are willing and able to fulfill the requirements of the study protocol * Mild to moderate hypertensive * Mild hypertension range (140-159/90-99 mm Hg) * Moderate hypertension range (160-179/100-109 mm Hg) * Be between the age of 30 to 60 year Exclusion Criteria: * Patients with recent history of following will be excluded: * Severe hypertension, * Congestive cardiac failure, * Left ventricular failure, * Myocardial ischemia, * Renal failure or * Cerebrovascular accidents
💊

What it tests

  • Qurs e Fishar
📍

Where

1 site
Taj Medical Complex, Hamdard University Hospital
Karachi, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy